5A60.0

ICD-11 MMS 2026-01

Acromegaly or pituitary gigantism

Description

Acromegaly is an acquired disorder related to excessive production of growth hormone (GH) and characterised by progressive somatic disfigurement (mainly involving the face and extremities) and systemic manifestations. The main clinical features are broadened extremities (hands and feet), widened thickened and stubby fingers, and thickened soft tissue. The disease also has rheumatologic, cardiovascular, respiratory and metabolic consequences which determine its prognosis. In the majority of cases, acromegaly is related to a pituitary adenoma, either purely GH-secreting (60%) or mixed. Transsphenoidal surgery is often the first-line treatment. When surgery fails to correct GH/IGF-I hypersecretion, medical treatment with somatostatin analogs and/or radiotherapy can be used.

Index terms

  • Acromegaly or pituitary gigantism
  • Launois syndrome
  • Marie disease
Show allHide
  • Overproduction of growth hormone
  • acromegalia
  • acromegalic gigantism
  • acromegaly
  • anterior pituitary adenoma syndrome
  • disorders with tall stature
  • genetic giant
  • giant
  • giantism
  • gigantism
  • growth hormone hypersecretion
  • growth hormone hypersecretion syndrome
  • hypersomatotropic gigantism
  • hypersomatotropism
  • hypophyseal gigantism
  • normal giant
  • pituitary gigantism
  • primordial giant
  • Cardiomyopathy associated with acromegaly
  • Somatotroph adenoma
  • Arthropathy associated with acromegaly
  • acromegalic arthritis
  • acromegalic arthropathy
  • acromegaly with arthropathy

Inclusions

  • Overproduction of growth hormone

Excludes

  • 5B12 – Constitutional tall stature
  • http://id.who.int/icd/entity/1283179793 – increased secretion from endocrine pancreas of growth hormone-releasing hormone

Exclusions from above levels

  • 2F7A.0 – Multiple endocrine neoplasia type 4
  • 5A02.Y – overproduction of thyroid-stimulating hormone
  • 5A70 – Cushing syndrome
Show allHide
  • 5A70.0 – overproduction of pituitary ACTH
  • 5A70.3 – Nelson syndrome
  • 18 – Pregnancy, childbirth or the puerperium
  • http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Sibling codes

  • 5A60.1 – Hyperprolactinaemia
  • 5A60.2 – Syndrome of inappropriate secretion of antidiuretic hormone
  • 5A60.3 – Central precocious puberty
  • 5A60.Y – Other specified hyperfunction of pituitary gland
  • 5A60.Z – Hyperfunction of pituitary gland, unspecified

Foundation entity

Acromegaly or pituitary gigantism – http://id.who.int/icd/entity/825410563

Allowed postcoordination axes

Part of: 5A60: Hyperfunction of pituitary gland › 05: Endocrine, nutritional or metabolic diseases